Hilo, a blood-pressure monitoring company developed by Switzerland's Aktiia, raised a $19 million Series B extension, CEO Stefan Petzinger tells Axios exclusively.
Why it matters: Investors and consumers increasingly prefer wearables that can compete with general-purpose devices on clinical credibility.
